IgG4-related ophthalmic disease

Por Mejico, Luis J.
Publicado no Saudi J Ophthalmol (2014)

Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients

Por Christophi, George P., Christophi, Jennifer A., Gruber, Ross C., Mihai, Cornelia, Mejico, Luis J., Massa, Paul T., Jubelt, Burk
Publicado em 2011

Interferon-β treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1

Por Christophi, George P., Panos, Michael, Hudson, Chad A., Tsikkou, Chriso, Mihai, Cornelia, Mejico, Luis J., Jubelt, Burk, Massa, Paul T.
Publicado em 2009

SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients

Por Christophi, George P, Hudson, Chad A, Gruber, Ross C, Christophi, Christoforos P, Mihai, Cornelia, Mejico, Luis J, Jubelt, Burk, Massa, Paul T
Publicado em 2008